Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
NA-901 by Biomed Industries for Alzheimer's Disease: Likelihood of Approval
NA-901 is under clinical development by Biomed Industries and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase...
Data Insights
NA-901 by Biomed Industries for Major Depressive Disorder: Likelihood of Approval
NA-901 is under clinical development by Biomed Industries and currently in Phase III for Major Depressive Disorder. According to GlobalData,...